Chance discovery links inflammatory bowel disease with common bacterial gut toxin

May 17, 2018, John Innes Centre
Professor Tony Maxwell's team at the John Innes Centre, Norwich, worked with colleagues at Brigham and Women's Hospital (Boston, USA) to uncover the surprise link. Credit: Andrew Davis

New research has uncovered a surprise link between a common bacterial toxin found in the gut and inflammatory bowel disease (IBD).

The researchers at the John Innes Centre, Norwich, UK, working alongside a team of scientists from Brigham and Women's Hospital (Boston, USA), have helped establish a connection between microcin B17, a well-known toxin produced by E. coli bacteria, and IBD.

IBD includes long-term conditions such Crohn's disease and ulcerative colitis which together affect more than 300,000 people in the UK.

The research, published today in the peer-reviewed journal Cell, raises prospects of future therapy for IBD sufferers.

The John Innes Centre scientists, led by Professor Tony Maxwell, have been working with microcin B17 for several years in their search for new antibiotics. It is produced by E. coli (Escherichia coli) as a weapon against other bacteria in the gut.

Professor Maxwell says: 'This is largely a chance finding. We have been studying this toxin for its antibacterial properties and we were contacted by Professor Richard Blumberg who leads the Boston group for quite different reasons—they thought there might be a connection between the toxin and IBD."

The two teams worked together to show that breakdown products from the toxin seem to trigger that is characteristic of IBD.

The research, furthermore, identifies the oxazole class of aromatic organic compounds as a new source of environmental and microbial triggers of gastrointestinal inflammation.

Dr. Fred Collin, a postdoctoral researcher in Professor Maxwell's lab, who carried out key aspects of the work says: 'These findings will advance our understanding of how gut inflammation associated with IBD may be triggered and offer new hope of potential future therapy."

The research team say that advances in genome-wide association studies have established genetic links with the development of IBD. But environmental elements and host reactions have yet to bet precisely defined.

In addition to increasing public understanding of IBD, the study sheds new light on the microbiome, the trillions of bacteria in the gut.

"The bacteria that live inside us have a lot of impact on well-being and the twist here is that it's not the E. coli bacteria but the toxin that's produced by the that appears to have an effect," explains Professor Maxwell.

"They produce these toxins to kill their neighbours in their fight for ecological niches but it appears that the breakdown products of the can initiate gut inflammation," he adds.

Explore further: E. coli's internal bomb may provide novel target for treatment strategy

More information: Cell (2018). DOI: 10.1016/j.cell.2018.04.037

Related Stories

E. coli's internal bomb may provide novel target for treatment strategy

April 21, 2018
Bacteria's internal bomb, the so-called toxin-antitoxin (TA) system that is part of the normal bacterial makeup, may be triggered to make bacteria turn on themselves, providing a valuable target for novel antimicrobial approaches ...

Shiga toxin-producing E. coli in food

May 9, 2018
Escherichia coli (E. coli) is a germ that occurs naturally in the gut of mammals and birds, as well as in the human intestinal flora. However, certain E. coli types can cause severe diarrhea in humans. These virulent E. coli ...

Recommended for you

Fatty acids can slow down an overheated immune system

September 21, 2018
Sometimes, the immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist. This causes chronic inflammation and leads to diseases including lupus (SLE), and this is what happens ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Rethinking an inflammatory receptor's obesity connection

September 12, 2018
Toll-like receptor 4 (TLR4) is a protein that plays a vital role in the body's immune response by sensing the presence of infection. It has long been thought to also sense particular types of fats, which suggested a mechanism ...

Excessive airway nerves tied to more severe asthma symptoms, study finds

September 5, 2018
A new study implicates remodeling of nerves in the airways as a key contributor to heightened sensitivity and airway constriction in patients with asthma.

Genetics and pollution drive severity of asthma symptoms

August 31, 2018
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared ...

Clarifying the role of a protein released by immune 'dendritic' cells could yield better treatments

August 30, 2018
Inflammatory bowel disease (IBD), which afflicts millions of people worldwide, arises when the immune system mounts an overly aggressive response against microorganisms, dietary substances, or cells of the gut. A*STAR researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.